← FDA Drug Approvals (Drugs@FDA)

LACOSAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2022-04-07

Drug application

FDA Application #

ANDA214301

Application type

Abbreviated New Drug Application (Generic)

Brand name

LACOSAMIDE

Generic name

LACOSAMIDE

Active ingredients

LACOSAMIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

REGCON HOLDINGS

Manufacturer

Sagent Pharmaceuticals

First approval

2022-04-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown